Knowledge and awareness of human papillomavirus (HPV): Attitudes towards HPV vaccination among a representative sample of women in Victoria, Australia

Sexual Health

Volumn 4, Issue 3, 2007, Pages 177-180

  Pitts, Marian K ^a   Dyson, Suzanne J ^a   Rosenthal, Doreen A ^b   Garland, Suzanne M ^c  

^a LA TROBE UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

Cervical cancer

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; ATTITUDE TO HEALTH; AUSTRALIA; AWARENESS; CONTROLLED STUDY; FEMALE; HEALTH PROMOTION; HEALTH SURVEY; HUMAN; KNOWLEDGE; MEDICAL INFORMATION; VACCINATION; VIRUS INFECTION; WART VIRUS; WOMEN'S HEALTH;

ADULT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MASS IMMUNIZATION; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; QUALITY OF LIFE; QUESTIONNAIRES; UTERINE CERVICAL NEOPLASMS; VICTORIA; WOMEN'S HEALTH;

EID: 34548317316     PISSN: 14485028     EISSN: None     Source Type: Journal    
DOI: 10.1071/SH07023     Document Type: Article

References (15)

1. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347: 1645-51. doi: 10.1056/NEJMoa020586
2. Harper DM, Franc EL, Wheeler C, Ferris D, Jenkins D, Schiund A, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. GlaxoSmithKline HPV vaccine study group. Lancet 2004; 364: 1757-65. doi: 10.1016/S0140-6736(04)17398-4
3. IDSA abstract Oct 2005 43rd Annual meeting of IDSA, October 6-9 2005, San Francisco, Prophylactic quadrivalent human papillomavirus (HPV) (types 6, 11, 16, 18) L1 virus-like particle (VLP) vaccine (Gardasil) reduces cervical intraepithelial neoplasia (CIN) 2/3 risk Skjeldestad F for the Future II Steering Committee; Dept of Epidemiology, SINTEF Health Research, Trondheim, Norway.
4. Efficacy of a prophylactic quadrivalent human papillomavirus (HPV) (Types 6, 11, 16, 18) L1 Virus-like particle (VLP) vaccine for Prevention of cervical dysplasia and external genital lesions (EGL) D Harper, for the FUTURE Investigators. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 2005 December 16-19; Washington, DC.
5. Baer H, Allen S, Braun L. Knowledge of human papillomavirus infection among young adult men and women: implication for the health education and research. J Community Health 2000; 25: 67-78. doi: 10.1023/A: 1005192902137
6. Boyd C. An assessment of college students' knowledge and perception of risk regarding human papilloma virus and related health promotion strategies for campus health personnel. [Ph.D]: Ohio University, 1998.
7. Holcomb B, Bailey JM, Crawford K, Ruffin MT. Adults' knowledge and behaviors related to human papillomavirus infection. J Am Board Fam Pract 2004; 17: 26-31.
8. Hoover DR, Carfoli B, Moench E. Attitudes of adolescent/young adult women towards human papillomavirus vaccination and clinical trials. Health Care Women Int 2000; 21: 375-91. doi: 10.1080/07399330050082227
9. Mays RM, Zimet G, Winston Y, Kee R, Dickes J, Su L. Human papillomavirus, genital warts, Pap smears, and cervical cancer: knowledge and beliefs of adolescent and adult women. Health Care Women Int 2000; 21: 361-74. doi: 10.1080/07399330050082218
10. Pitts MK, Clarke T. Human papillomavirus infections and risks of cervical cancer: what do women know? Health Educ Res 2002; 17: 706-14. doi: 10.1093/her/17.6.706
11. Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Wardle J. Awareness of human papillomavirus among women attending a well women clinic. Sex Transm Infect 2003; 79: 320-2. doi: 10.1136/sti.79.4.320
12. Gudmundsdóttir T, Tryggvadóttir L, Allende M, Mast T. Eligibility and willingness of young Icelandic women to participate in a HPV vaccination trial. Acta Obstet Gynecol Scand 2003; 82: 345-50. doi: 10.1034/j.1600-0412.2003.00086.x
13. McClelland A, Liamputtong P. Knowledge and acceptance of human papillomavirus vaccination: perspectives of young Australians living in Melbourne, Australia Sex Health 2006; 3: 95-101. doi: 10.1071/SH05035
14. Brabin L, Roberts SA, Farzaneh F, Kitchener H. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine 2006; 24: 3087-94. doi: 10.1016/j.vaccine.2006.01.048
15. Garland SM. Human papillomavirus vaccines: challenges to implementation. Sex Health 2006; 3: 63-5. doi: 10.1071/SH06018